Envestnet Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $469K | Buy |
33,538
+2,108
| +7% | +$29.5K | ﹤0.01% | 3734 |
|
|
2025
Q1 | $427K | Sell |
31,430
-6,192
| -16% | -$84.2K | ﹤0.01% | 3712 |
|
|
2024
Q4 | $767K | Buy |
37,622
+9,643
| +34% | +$197K | ﹤0.01% | 3333 |
|
|
2024
Q3 | $815K | Buy |
27,979
+6,838
| +32% | +$199K | ﹤0.01% | 3250 |
|
|
2024
Q2 | $491K | Sell |
21,141
-1,155
| -5% | -$26.8K | ﹤0.01% | 3470 |
|
|
2024
Q1 | $458K | Sell |
22,296
-1,265
| -5% | -$26K | ﹤0.01% | 3497 |
|
|
2023
Q4 | $506K | Buy |
23,561
+440
| +2% | +$9.44K | ﹤0.01% | 3319 |
|
|
2023
Q3 | $477K | Buy |
23,121
+7,498
| +48% | +$155K | ﹤0.01% | 3281 |
|
|
2023
Q2 | $461K | Sell |
15,623
-25,814
| -62% | -$762K | ﹤0.01% | 3259 |
|
|
2023
Q1 | $955K | Buy |
41,437
+520
| +1% | +$12K | ﹤0.01% | 2705 |
|
|
2022
Q4 | $1.14M | Sell |
40,917
-599
| -1% | -$16.7K | ﹤0.01% | 2542 |
|
|
2022
Q3 | $1.27M | Buy |
41,516
+11,073
| +36% | +$340K | ﹤0.01% | 2368 |
|
|
2022
Q2 | $896K | Sell |
30,443
-2,915
| -9% | -$85.8K | ﹤0.01% | 2681 |
|
|
2022
Q1 | $1.07M | Buy |
33,358
+4,795
| +17% | +$154K | ﹤0.01% | 2610 |
|
|
2021
Q4 | $1.27M | Buy |
28,563
+2,312
| +9% | +$103K | ﹤0.01% | 2463 |
|
|
2021
Q3 | $1.32M | Buy |
+26,251
| New | +$1.32M | ﹤0.01% | 2360 |
|